Concepedia

Niranjan Awasthi

NA

Statistics

Publications

43

Citations

1.8K

H-Index

25

Active since

2002

Affiliations

The University of Texas Southwestern Medical Center(Current)

Indiana University School of Medicine

Goshen Health

University of Notre Dame

Indiana University South Bend

Niranjan Awasthi is an author at The University of Texas Southwestern Medical Center specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2002–2021

43

Publications

43

A C-X-C Chemokine Receptor Type 2–Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis

Zhijun Zhou, Guanggai Xia, Zhen Xiang et al. · Clinical Cancer Research · 2019 · 133 citations · Full text

, , +17

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

Niranjan Awasthi, Chenyue Zhang, Anna Schwarz et al. · Carcinogenesis · 2013 · 126 citations · Full text

, , +16

A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis

Zhenxian Xiang, G-K Xia, X-H Zhang et al. · Oncogene · 2017 · 98 citations

, , +14

CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer

Zhe-Wei Wei, Guang-Kai Xia, Ying Wu et al. · Cancer Letters · 2015 · 96 citations

, , +12

The efficacy of a novel, dual PI3K/mTOR inhibitor NVP‐BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer

Niranjan Awasthi, Peter L. Yen, Margaret A. Schwarz et al. · Journal of Cellular Biochemistry · 2011 · 87 citations

, , +17

1–5 of 43